ALS (Lou Gehrig’s Disease)

ALS (Lou Gehrig’s Disease) is a neurodegenerative disorder that primarily affects the motor system but is increasingly recognized to have extra-motor manifestations. The progressive loss of upper and lower motor neurons in the motor cortex, brainstem nuclei, and spinal cord’s anterior horn leads to gradual muscle weakness and wasting. ALS typically starts in a specific area but eventually spreads to other regions of the body. Respiratory muscle failure often limits survival to 2-5 years after the onset of the disease.

In the past two decades, regenerative cell therapy, also known as stem cell therapy, has emerged as a promising avenue for exploring innovative strategies to treat neurodegenerative diseases. Stem cells have the remarkable ability to repair damaged neuronal tissue by replacing lost or damaged cells with differentiated cells. They can create an environment conducive to regeneration, or they can protect existing healthy neurons and glial cells from further damage.

ALS regeneration clinic

Citations and Scientific References

Our medical unit is highly esteemed for partnering globally with fellow researchers on scientific studies and contributing to respected scientific journals.

View References